Novozymes A/S ADR | Cash Flow
Fiscal year is January-December. All values DKK Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
2,201
2,525
2,825
3,050
3,120
3,227
Depreciation, Depletion & Amortization
738
866
953
974
1,040
1,011
Other Funds
167
1
398
-
-
438
Funds from Operations
3,107
2,820
3,885
4,154
4,312
4,526
Changes in Working Capital
508
1,705
546
314
249
847
Net Operating Cash Flow
2,599
4,525
3,339
3,840
4,063
3,679
Capital Expenditures
786
723
1,031
1,216
1,692
Sale of Fixed Assets & Businesses
3
18
16
28
31
Purchase/Sale of Investments
-
-
-
15
-
Net Investing Cash Flow
1,423
310
1,257
1,349
1,668
Cash Dividends Paid - Total
692
787
925
1,061
1,192
Issuance/Reduction of Debt, Net
7
-
484
508
198
Net Financing Cash Flow
532
2,703
3,681
2,484
2,815
Net Change in Cash
612
1,511
1,657
9
442
Free Cash Flow
1,837
3,822
2,371
2,764
2,470
Deferred Taxes & Investment Tax Credit
-
-
-
-
220
150
Net Assets from Acquisitions
640
14
242
146
-
Other Sources
-
409
-
-
-
Change in Capital Stock
-
1,915
1,874
1,931
1,821
Exchange Rate Effect
32
1
58
2
22
About Novozymes A/S
View Profile
